172 related articles for article (PubMed ID: 11959219)
21. [Pulmonary infections following solid organ transplantation].
Müller V; Kováts Z; Horváth G
Orv Hetil; 2012 Jun; 153(23):899-903. PubMed ID: 22668590
[TBL] [Abstract][Full Text] [Related]
22. Steroid withdrawal in renal transplant recipients.
Oppenheimer F
Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
[No Abstract] [Full Text] [Related]
23. Induction therapy: why, when, and which agent?
Krischock L; Marks SD
Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
[TBL] [Abstract][Full Text] [Related]
25. [New perspectives in immunosuppression].
Sádaba B; Azanza JR; Muñoz MJ; Gil I
Nefrologia; 2005; 25(5):475-84, 486-8, 490-2. PubMed ID: 16392297
[No Abstract] [Full Text] [Related]
26. New directions for induction immunosuppression strategy in solid organ transplantation.
Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
[TBL] [Abstract][Full Text] [Related]
27. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
[No Abstract] [Full Text] [Related]
28. Posttransplant cardiovascular risk: impact on long-term patient survival. Introduction.
Vanrenterghem Y
Transplantation; 2001 Sep; 72(6 Suppl):S4. PubMed ID: 11585241
[No Abstract] [Full Text] [Related]
29. Dyslipidemia and its management after renal transplantation.
Andany MA; Kasiske BL
J Nephrol; 2001; 14 Suppl 4():S81-8. PubMed ID: 11798152
[TBL] [Abstract][Full Text] [Related]
30. The effect of immunosuppression on growth and development.
Balistreri WF; Bucuvalas JC; Ryckman FC
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):64-73. PubMed ID: 9346602
[No Abstract] [Full Text] [Related]
31. Noncompliance with immunosuppressive regimen in organ transplantation: is it worth worrying about?
Desmyttere A; Dobbels F; Cleemput I; De Geest S
Acta Gastroenterol Belg; 2005; 68(3):347-52. PubMed ID: 16268422
[No Abstract] [Full Text] [Related]
32. [Xenotransplantation is the hope of the future. Genetic modification of the donor, the pig, is better than fighting organ rejection by submitting patients to immunosuppression with frequent side effect].
Groth CG
Lakartidningen; 2002 Jan; 99(4):252-4. PubMed ID: 11871187
[No Abstract] [Full Text] [Related]
33. New immunosuppressive strategies and the risk of infection.
Mueller NJ
Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
[TBL] [Abstract][Full Text] [Related]
34. Uterine transplantation: what else needs to be done before it can become a reality?
Saso S; Ghaem-Maghami S; Louis LS; Ungar L; Del Priore G; Smith JR
J Obstet Gynaecol; 2013 Apr; 33(3):232-8. PubMed ID: 23550848
[TBL] [Abstract][Full Text] [Related]
35. [Immunosuppression after organ transplantation].
Wagner K; Erhard J
Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470
[TBL] [Abstract][Full Text] [Related]
36. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Manu M; Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shimmura H; Inui M; Harano M; Shiroyanagi Y; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1736-8. PubMed ID: 11119912
[No Abstract] [Full Text] [Related]
37. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of over-immunosuppression.
Budde K; Matz M; Dürr M; Glander P
Clin Pharmacol Ther; 2011 Aug; 90(2):316-22. PubMed ID: 21716278
[No Abstract] [Full Text] [Related]
39. [Toward an evidence-based immunosuppression].
Pascual J
Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
[No Abstract] [Full Text] [Related]
40. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
